4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0000885590-14-000028
$BHCCIK 0000885590operating
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 7:19 PM ET
Size
6.2 KB
Accession
0000885590-14-000028
Insider Transaction Report
Form 4
Pearson J. Michael
DirectorChief Executive Officer
Transactions
- Award
Restricted Share Units
2014-03-11+502,996→ 502,996 total→ Common Shares, no par value (502,996 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents the right to receive one share of Registrant common stock.
- [F2]On May 24, 2013, the Registrant delivered 502,996 vested performance share units (the "2010 PSU Grant") to Mr. Pearson in error. In connection with Mr. Pearson returning to the Registrant the value of such shares on the date of delivery (plus interest), Mr. Pearson has been credited with 502,996 vested share units to be delivered to him in accordance with the terms of the original 2010 PSU Grant.
- [F3]The performance based RSUs vested on May 24, 2013 on achievement of the applicable performance criteria. The performance based RSUs are generally not issuable until 2019 pursuant to Mr. Pearson's employment agreement.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 7:19 PM ET
- Size
- 6.2 KB